71-Year-old man with shortness of breath and rash

Mayo Clinic Proceedings

Volumn 83, Issue 12, 2008, Pages 1388-1391

  Maripuri, Saugar ^a   Fervenza, Fernando C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; CEFTRIAXONE; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; PREDNISONE; SALBUTAMOL;

AGED; ANAPHYLACTOID PURPURA; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DYSPNEA; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; LABORATORY TEST; MALE; NOTE; RASH; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

EID: 57349126270     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.12.1388     Document Type: Article

References (15)

1. Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M, González-Gay MA. Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum. 1997;40(5):859-864.
2. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998;41(9):1521-1537.
3. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63(3):1164-1177.
4. Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7(1):33-39.
5. Jayne DR, Gaskin G, Rasmussen N, et al; European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007 Jul;18(7):2180-2188. Epub 2007 Jun 20.
6. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med. 2006 Jan 15;173(2):180-187. Epub 2005 Oct 13.
7. Fervenza FC. Henoch-Schönlein purpura nephritis. Int J Dermatol. 2003;42(3):170-177.
8. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005 Sep;90(9):916-920. Epub 2005 May 4.
9. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187-192.
10. Jennette JC, Falk RJ. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol. 2008;20(1):55-60.
11. Maejima H, Shirai K, Shimamura Y, Harada H, Eto H. Microscopic polyangiitis presenting urticarial erythema and Henoch-Schönlein purpura: two case reports. J Dermatol. 2004;31(8):655-660.
12. Miyata M, Kanno K, Nishimaki T, Sakuma F, Iwatsuki K, Kasukawa R. A patient with Wegener's granulomatosis with initial clinical presentations of Henoch-Schönlein purpura. Intern Med. 2001;40(10):1050-1054.
13. Ronda N, Esnault VL, Layward L, et al. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol. 1994;95(1):49-55.
14. Stefanidis I, Helmchen U, Schmitt H, Maurin N, Sieberth HG. Coincidence of haemolytic uraemic syndrome and c-ANCA-associated rapidly progressive glomerulonephritis. Nephrol Dial Transplant. 1998;13(7):1818-1821.
15. Lapraik C, Watts R, Bacon P, et al; BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford). 2007 Oct;46(10):1615-1616. Epub 2007 Sep 5.